HomeBiosimilar Antibodies

Biosimilar Antibodies

Cat.No. Product Name Information Isotype
A3005 Anti-MUC1 (AR20.5) Anti-MUC1 (AR20.5) is a murine monoclonal antibody targeting tumor-associated antigen MUC1. It has anti-tumor activity and can be used in research of potential cancer vaccine. MW :140.36 KD. Human IgG1
A2750 Anti-FcgR3a / CD16a (AFM13) Anti-FcgR3a / CD16a (AFM13) is a tetravalent bispecific antibody directed against human CD30 and the human low affinity IgG Fc region receptor (FCGR3A; CD16A), with potential immunomodulating and antineoplastic activities. MW: 124.56 kD. Human IgG2SA
A3006 Anti-INHBB / Activin B Anti-INHBB / Activin B is a monoclonal antibody targeting the betaB subunit of Activin B. It has potent uses in treatment of fatigue syndrome/myalgic encephalomyelitis (CFS/ME). MW:146.02 KD. Human IgG1
A3007 Anti-NGF / bNGF (AS2886401-00) Anti-NGF / bNGF (AS2886401-00) is a monoclonal antibody targeting nerve growth factor (NGF). It holds tremendous potential for the management of osteoarthritis (OA). MW :139.0 KD. Human IgG2SA
A2752 Anti-MUSK Anti-MUSK is a monoclonal IgG antibody against muscle-specific kinase (MuSK) with the potential to treat Myasthenia gravis. MW: 145.24 KD. Human IgG1
A3008 Fasinumab (Anti-NGF / bNGF) Fasinumab (Anti-NGF / bNGF) is a human IgG1k monoclonal antibody targeting nerve growth factor (NGF). It can be used in acute sciatica and knee osteoarthritis (OA) studies. MW :144.9 KD. Human IgG1
A2753 Anti-MICA (CLN-619) Anti-MICA (CLN-619) is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the natural-killer group 2, member D receptor protein (NKG2D or KLRK1) ligands MHC class I polypeptide-related sequence A (MICA) and B (MICB), with potential immunostimulating and antineoplastic activities. MW: 146.06 kD. Human IgG1
A3009 Anti-NGF / bNGF (MEDI-578) Anti-NGF / bNGF (MEDI-578) is a monoclonal antibody targeting nerve growth factor (NGF). It holds tremendous potential for the management of osteoarthritis (OA). MW :145.42 KD. Human IgG4SP
A2754 Anti-TREM1 / CD354 (PY159) Anti-TREM1 / CD354 (PY159) is a humanized agonistic monoclonal antibody targeting triggering receptor expressed on myeloid cells 1 (TREM1), with potential immunomodulating and antineoplastic activities. MW: 143.66 kD. Human IgG1
A3010 Uliledlimab (Anti-NT5E / CD73) Uliledlimab (Anti-NT5E / CD73) is a humanized monoclonal antibody targeting CD73. It can be used in research of cancer and treatment naive NSCLC. MW :145.06 KD. Human IgG1
A2755 Anti-CDH11 / Cadherin-11 (RG6125) Anti-CDH11 / Cadherin-11 (RG6125) is a humanized monoclonal antibody that binds cadherin 11 an adhesion molecule expressed by FLS that is involved in synovial intimal lining aggregation. It has the potential to research FLS-targeted rheumatoid arthritis. MW: 146.4 kD. Human IgG2SA
A2756 Anti-SCN11a / Nav1.9 Anti-SCN11a / Nav1.9 is a monoclonal anti-Nav1.9 (SCN11A) antibody used in antigen-specific immunodetection in biological samples. MW: 143.94 KD. Human IgG1
A3012 Vixarelimab (Anti-OSMR) Vixarelimab (Anti-OSMR) is a human monoclonal antibody that targets oncostatin M (OSM). It can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash. MW :145.34 KD. Human IgG4SP
A2757 Anti-TLR7 Anti-TLR7 is a monoclonal antibody against Toll-like receptor 7 (TLR7) with the potential to treat autoimmune disease. MW: 145.04 KD. Human IgG1
A3013 Plonmarlimab (Anti-CSF2 / GM-CSF) Plonmarlimab (Anti-CSF2 / GM-CSF) is a monoclonal antibody targeting GM-CSF. It can be used for research of rheumatoid arthritis and COVID-19. MW :145.96 KD. Human IgG1
A3173 Minretumomab (CC-49) Minretumomab (CC-49) is a monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72). Minretumomab can be used in cancer and immunity research. Human IgG1-Kappa
A2758 Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD. Human IgG1
A3014 Ponezumab (Anti-Amyloid Beta) Ponezumab (Anti-Amyloid Beta) is a humanised IgG2 monoclonal antibody amyloid. It can be used in study of Alzheimer's disease. MW :145.66 KD. Human IgG2SA
A2759 Selicrelumab (Anti-TNFRSF5 / CD40) Selicrelumab (anti-TNFRSF5 / CD40) is a human immunoglobulin G2 (IgG2) monoclonal antibody agonist of the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. It induces changes in the tumor microenvironment and can be used for the research of pancreatic cancer and neoadjuvant tudies. MW: 146.2 kD. Human IgG2SA
A2760 Lintuzumab (Anti-Siglec-3 / CD33) Lintuzumab (HuM195) is a humanized monoclonal antibody that targets CD33, a 67-kDa cell surface glycoprotein expressed on most myeloid leukemia cells. MW: 145. 24 kD. Human IgG1